Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Nucleic Acids Research|June 1, 2021
DrugComb update: a more comprehensive drug sensitivity data repository and analysis portalShuyu Zheng, Jehad Aldahdooh, Tolou Shadbahr, et al.
Genomics, Proteomics & Bioinformatics|January 27, 2022
SynergyFinder Plus: Toward Better Interpretation and Annotation of Drug Combination Screening DatasetsShuyu Zheng, Wenyu Wang, Jehad Aldahdooh, et al.
BJU International|December 15, 2025
Comparable recurrence risk for MRI-detected Gleason Grade Group (GG) 2 and systematic biopsy-detected GG1 prostate cancerAbderrahim-Oussama Batouche, Eugen Czeizler, Timo-Pekka Lehto, et al.
Medrxiv : the Preprint Server for Health Sciences|January 23, 2024
MRI-Targeted Prostate Biopsy Introduces Grade Inflation and OvertreatmentAbderrahim Oussama Batouche, Eugen Czeizler, Timo-Pekka Lehto, et al.
Patterns (New York, N.Y.)|July 15, 2024
Recent methodological advances in federated learning for healthcareFan Zhang, Daniel Kreuter, Yichen Chen, et al.
European Urology Oncology|May 8, 2026
PI-RADS v2 and Adverse Prostate Cancer Outcomes: A Cross-cohort Replication Study Across Three CentersTolou Shadbahr, Juho Pylväläinen, Juho Eineluoto, et al.
Communications Medicine|October 6, 2023
The impact of imputation quality on machine learning classifiers for datasets with missing valuesTolou Shadbahr, Michael Roberts, Jan Stanczuk, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 21, 2025
Targeting SARS-CoV-2 RNA-dependent RNA polymerase with the coumarin derivative BPR2-D2: Evidence from cell-based and enzymatic studiesWen-Fang Tang, Hui-Ping Tsai, Yuan-Fan Chin, et al.
Antimicrobial Agents and Chemotherapy|March 6, 2024
BPR3P0128, a non-nucleoside RNA-dependent RNA polymerase inhibitor, inhibits SARS-CoV-2 variants of concern and exerts synergistic antiviral activity in combination with remdesivirWen-Fang Tang, Yu-Hsiu Chang, Cheng-Chin Lin, et al.
Pageof 1